{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T21:09:13Z","timestamp":1783544953632,"version":"3.55.0"},"reference-count":119,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2005,1,1]],"date-time":"2005-01-01T00:00:00Z","timestamp":1104537600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinica Chimica Acta"],"published-print":{"date-parts":[[2005,1]]},"DOI":"10.1016\/j.cccn.2004.09.005","type":"journal-article","created":{"date-parts":[[2004,11,12]],"date-time":"2004-11-12T17:22:34Z","timestamp":1100280154000},"page":"31-47","source":"Crossref","is-referenced-by-count":147,"title":["Drug-induced renal failure: a focus on tubulointerstitial disease"],"prefix":"10.1016","volume":"351","author":[{"given":"Glen S.","family":"Markowitz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark A.","family":"Perazella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cccn.2004.09.005_bib1","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1097\/00005792-197711000-00003","article-title":"Methicillin nephritis","volume":"56","author":"Ditlove","year":"1977","journal-title":"Medicine"},{"key":"10.1016\/j.cccn.2004.09.005_bib2","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1159\/000413416","article-title":"Renal toxicity of nonsteroidal anti-inflammatory drugs","volume":"55","author":"Pirani","year":"1987","journal-title":"Contrib. Nephrol."},{"key":"10.1016\/j.cccn.2004.09.005_bib3","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1056\/NEJM197408222910803","article-title":"Antitubular basement-membrane antibodies in methicillin-associated interstitial nephritis","volume":"291","author":"Border","year":"1974","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.cccn.2004.09.005_bib4","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/S0022-2143(98)90060-9","article-title":"The role of oxygen free radicals in cisplatin-induced acute renal failure in rats","volume":"131","author":"Matushima","year":"1998","journal-title":"J. Lab. Clin. Med."},{"key":"10.1016\/j.cccn.2004.09.005_bib5","first-page":"2538","article-title":"Effects of cis-diamminedichloroplatinum (II) on rabbit kidney in vivo or rabbit renal proximal tubule cells in culture","volume":"48","author":"Tay","year":"1988","journal-title":"Cancer Res."},{"key":"10.1016\/j.cccn.2004.09.005_bib6","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1038\/ki.1995.348","article-title":"Critical subcellular targets of cisplatin and related platinum analogs in rat renal proximal tubule cells","volume":"48","author":"Leibbrandt","year":"1995","journal-title":"Kidney Int."},{"key":"10.1016\/j.cccn.2004.09.005_bib7","doi-asserted-by":"crossref","first-page":"351","DOI":"10.3109\/08860229209106642","article-title":"Drug-phospholipid interactions: role in aminoglycoside nephrotoxicity","volume":"14","author":"Kaloyanides","year":"1992","journal-title":"Ren. Fail."},{"key":"10.1016\/j.cccn.2004.09.005_bib8","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1172\/JCI113325","article-title":"Evidence suggesting a role for hydroxyl radical in gentamicin-induced acute renal failure in rats","volume":"81","author":"Walker","year":"1988","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.cccn.2004.09.005_bib9","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1172\/JCI115240","article-title":"Direct vasoconstriction as a possible cause for amphotericin B-induced nephrotoxicity n rats","volume":"87","author":"Sawaya","year":"1991","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.cccn.2004.09.005_bib10","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1681\/ASN.V62154","article-title":"Amphotericin B nephrotoxicity: the adverse consequences of altered membrane properties","volume":"6","author":"Sawaya","year":"1995","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.cccn.2004.09.005_bib11","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1056\/NEJM198403013100905","article-title":"Renal syndromes associated with nonsteroidal anti-inflammatory drugs","volume":"310","author":"Clive","year":"1984","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.cccn.2004.09.005_bib12","first-page":"2133","article-title":"Nephrotoxicity of selective COX-2 inhibitors","volume":"28","author":"Woywodt","year":"2001","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.cccn.2004.09.005_bib13","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/S0002-9343(01)00757-4","article-title":"Selective cyclooxygenase-2 inhibitors: a pattern of nephrotoxicity similar to traditional nonsteroidal anti-inflammatory drugs","volume":"111","author":"Perazella","year":"2001","journal-title":"Am. J. Med."},{"key":"10.1016\/j.cccn.2004.09.005_bib14","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1016\/S0140-6736(00)05083-2","article-title":"Acute tubulointerstitial nephritis associated with the selective COX-2 enzyme inhibitor, rofecoxib","volume":"357","author":"Rocha","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.cccn.2004.09.005_bib15","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1053\/ajkd.2002.36349","article-title":"Nephrotic syndrome and interstitial nephritis associated with celecoxib","volume":"40","author":"Alper","year":"2002","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/j.cccn.2004.09.005_bib16","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1053\/ajkd.2002.33412","article-title":"Celecoxib-induced acute interstitial nephritis","volume":"39","author":"Henao","year":"2002","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/j.cccn.2004.09.005_bib17","doi-asserted-by":"crossref","first-page":"137","DOI":"10.5414\/CNP59137","article-title":"Membranous glomerulopathy and acute interstitial nephritis following treatment with celecoxib","volume":"59","author":"Markowitz","year":"2003","journal-title":"Clin. Nephrol."},{"key":"10.1016\/j.cccn.2004.09.005_bib18","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1093\/ndt\/gfh033","article-title":"Acute tubulolinterstitial nephritis associated with celecoxib","volume":"19","author":"Brewster","year":"2004","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.cccn.2004.09.005_bib19","doi-asserted-by":"crossref","first-page":"2961","DOI":"10.1002\/1097-0142(20000615)88:12+<2961::AID-CNCR12>3.0.CO;2-L","article-title":"Cellular and molecular mechanisms of action of bisphosphonates","volume":"88","author":"Rogers","year":"2000","journal-title":"Cancer"},{"key":"10.1016\/j.cccn.2004.09.005_bib20","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1681\/ASN.V1261164","article-title":"Collapsing focal segmental glomerulosclerosis following treatment with high-dose pamidronate","volume":"12","author":"Markowitz","year":"2001","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.cccn.2004.09.005_bib21","first-page":"377","article-title":"Zoledronic acid versus pamidronate in the treatment of skeletal metastases in patients with breast cancer or osteolytic lesions of multiple myeloma: a phase III, double-blind comparative trial","volume":"7","author":"Rosen","year":"2001","journal-title":"Cancer J."},{"issue":"1","key":"10.1016\/j.cccn.2004.09.005_bib22","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1046\/j.1523-1755.2003.00071.x","article-title":"Toxic acute tubular necrosis following treatment with zoledronate (Zometa)","volume":"64","author":"Markowitz","year":"2003","journal-title":"Kidney Int."},{"key":"10.1016\/j.cccn.2004.09.005_bib23","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1086\/514057","article-title":"Anti-human immunodeficiency virus (HIV) activity, safety, and pharmacokinetics of adefovir dipivoxil (9-[2-(bis-pivaloyloxymethyl)-phosphonylmethoxyethyl] adenine) in HIV-infected patients","volume":"176","author":"Barditch-Crovo","year":"1997","journal-title":"J. Inf. Disp."},{"key":"10.1016\/j.cccn.2004.09.005_bib24","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.1001\/jama.282.24.2305","article-title":"Efficacy and safety of adefovir dipivoxil with antiretroviral therapy; a randomized controlled trial","volume":"282","author":"Kahn","year":"1999","journal-title":"JAMA"},{"key":"10.1016\/j.cccn.2004.09.005_bib25","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1177\/095632029500600403","article-title":"Kinetic interaction of the diphosphates of 9-(2-phosphonylmethoxyethyl)adenine and other anti-HIV active purine congeners with HIV reverse transcriptase and human DNA polymerases \u03b1, \u03b2 and \u03b3","volume":"6","author":"Cherrington","year":"1995","journal-title":"Antivir. Chem. Chemother."},{"key":"10.1016\/j.cccn.2004.09.005_bib26","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1097\/00002030-199814000-00004","article-title":"Adverse effects of reverse transcriptase inhibitors; mitochondrial toxicity as common pathway","volume":"12","author":"Brinkman","year":"1998","journal-title":"AIDS"},{"key":"10.1016\/j.cccn.2004.09.005_bib27","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/0140-6736(91)91294-5","article-title":"Depletion of muscle mitochondrial DNA in AIDS patients with zidovudine-induced myopathy","volume":"337","author":"Arnaudo","year":"1991","journal-title":"Lancet"},{"key":"10.1016\/j.cccn.2004.09.005_bib28","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1053\/hupa.2001.25586","article-title":"Adefovir nephrotoxicity: possible role of mitochondrial DNA depletion","volume":"32","author":"Tanji","year":"2001","journal-title":"Human Pathol."},{"key":"10.1016\/j.cccn.2004.09.005_bib29","doi-asserted-by":"crossref","first-page":"S22","DOI":"10.1097\/00042560-199700001-00005","article-title":"Cidofovir: a new therapy for cytomegalovirus retinitis","volume":"14","author":"Lalezari","year":"1997","journal-title":"J. Acquir. Immune Defic. Syndr. Human Retrovirol."},{"key":"10.1016\/j.cccn.2004.09.005_bib30","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.1097\/00042560-199700001-00006","article-title":"Clinical experience with cidofovir in the treatment of cytomegalovirus retinitis","volume":"14","author":"Lalezari","year":"1997","journal-title":"J. Acquir. Immune Defic. Syndr. Human Retrovirol."},{"key":"10.1016\/j.cccn.2004.09.005_bib31","first-page":"264","article-title":"Parenteral cidofovir for cytomegalovirus retinitis in patients with AIDS: the HPMPC peripheral cytomegalovirus retinitis trial","volume":"126","year":"1999","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.cccn.2004.09.005_bib32","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1097\/00042560-199804010-00008","article-title":"Randomized, controlled study of the safety and efficacy of intravenous cidofovir for the treatment of relapsing cytomegalovirus retinitis in patients with AIDS","volume":"17","author":"Lalezari","year":"1998","journal-title":"J. Acquir. Immune Defic. Syndr. Human Retrovirol."},{"key":"10.1016\/j.cccn.2004.09.005_bib33","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1093\/ndt\/17.1.148","article-title":"Cidofovir-induced end-stage renal failure","volume":"17","author":"Meier","year":"2002","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.cccn.2004.09.005_bib34","doi-asserted-by":"crossref","first-page":"2401","DOI":"10.1128\/AAC.39.11.2401","article-title":"Clinical pharmacokinetics of adefovir in human immunodeficiency virus type 1-infected patients","volume":"39","author":"Cundy","year":"1995","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.cccn.2004.09.005_bib35","article-title":"Safety of adefovir dipivoxil (ADV) and incidence of proximal tubular disorders (PRTD) in a placebo-controlled trial in patients with advanced HIV disease [Abstract 678]","author":"Fisher","year":"1999"},{"key":"10.1016\/j.cccn.2004.09.005_bib36","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1097\/00002030-200206140-00008","article-title":"Tenofovir DF in antiretroviral-experienced patients: results from a 48-week, randomized, double-blind study","volume":"16","author":"Schooley","year":"2002","journal-title":"AIDS"},{"key":"10.1016\/j.cccn.2004.09.005_bib37","doi-asserted-by":"crossref","first-page":"2733","DOI":"10.1128\/AAC.45.10.2733-2739.2001","article-title":"PhaseI\/II trial of the pharmacokinetics, safety, and antiretroviral activity of tenofovir disoproxil fumarate in human immunodeficiency virus-infected adults","volume":"45","author":"Barditch-Crovo","year":"2001","journal-title":"Antimicrob. Agents Chemother."},{"issue":"6","key":"10.1016\/j.cccn.2004.09.005_bib38","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1097\/00000441-200212000-00011","article-title":"Rapid communication: acute renal failure associated with tenofovir: evidence of drug-induced nephrotoxicity","volume":"324","author":"Coca","year":"2002","journal-title":"Am. J. Med. Sci."},{"issue":"8","key":"10.1016\/j.cccn.2004.09.005_bib39","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1086\/368314","article-title":"Tenofovir-related nephrotoxicity in human immunodeficiency virus infected patients: three cases of renal failure, Fanconi syndrome, and nephrogenic diabetes insipidus","volume":"36","author":"Karras","year":"2003","journal-title":"Clin. Infect. Dis."},{"issue":"3","key":"10.1016\/j.cccn.2004.09.005_bib40","doi-asserted-by":"crossref","first-page":"e41","DOI":"10.1086\/376643","article-title":"Acute renal failure associated with tenofovir treatment in a patient with acquired immunodeficiency syndrome","volume":"e37","author":"Schaaf","year":"2003","journal-title":"Clin. Infect. Dis."},{"issue":"6","key":"10.1016\/j.cccn.2004.09.005_bib41","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1053\/ajkd.2002.36924","article-title":"Fanconi syndrome and renal failure induced by tenofovir: a first case report","volume":"40","author":"Verhelst","year":"2002","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/j.cccn.2004.09.005_bib42","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.amjmed.2004.03.025","article-title":"Tenofovir-associated nephrotoxicity: Fanconi syndrome and renal failure","volume":"117","author":"Rifkin","year":"2004","journal-title":"Am. J. Med."},{"key":"10.1016\/j.cccn.2004.09.005_bib43","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1681\/ASN.V113383","article-title":"Cytotoxicity of antiviral nucleotides adefovir and cidofovir is induced by the expression of human renal organic anion transporter 1","volume":"11","author":"Ho","year":"2000","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.cccn.2004.09.005_bib44","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1124\/mol.56.3.570","article-title":"The antiviral nucleotide analogs cidofovir and adefovir are novel substrates for human and rat renal organic anion transporter 1","volume":"56","author":"Cihlar","year":"1999","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.cccn.2004.09.005_bib45","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1097\/00041552-199809000-00006","article-title":"Renal transport of organic anions","volume":"7","author":"Roch-Ramel","year":"1998","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"key":"10.1016\/j.cccn.2004.09.005_bib46","doi-asserted-by":"crossref","first-page":"30088","DOI":"10.1074\/jbc.272.48.30088","article-title":"Expression cloning and characterization of ROAT1","volume":"272","author":"Sweet","year":"1997","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cccn.2004.09.005_bib47","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1172\/JCI117863","article-title":"Lithium-induced downregulation of aquaporin-2 water channel expression in rat kidney medulla","volume":"95","author":"Marples","year":"1995","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.cccn.2004.09.005_bib48","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1038\/ki.1977.102","article-title":"Chronic renal lesions following long-term treatment with lithium","volume":"12","author":"Hestbech","year":"1977","journal-title":"Kidney Int."},{"key":"10.1016\/j.cccn.2004.09.005_bib49","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1038\/ki.1981.191","article-title":"Renal function and biopsy findings in patients on long-term lithium treatment","volume":"20","author":"Aurell","year":"1981","journal-title":"Kidney Int."},{"key":"10.1016\/j.cccn.2004.09.005_bib50","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1681\/ASN.V1181439","article-title":"Lithium nephrotoxicity: a progressive combined glomerular and tubulointerstitial nephropathy","volume":"11","author":"Markowitz","year":"2000","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.cccn.2004.09.005_bib51","first-page":"267","article-title":"Nephrotic syndrome associated with lithium therapy","volume":"15","author":"Alexander","year":"1981","journal-title":"Clin. Nephrol."},{"key":"10.1016\/j.cccn.2004.09.005_bib52","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/S0272-6386(96)90108-0","article-title":"Nephrotic syndrome and renal insufficiency associated with lithium therapy","volume":"27","author":"Tamm","year":"1996","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/j.cccn.2004.09.005_bib53","first-page":"1983","article-title":"Renal lesions following administration of hypertonic solutions of sucrose","volume":"114","author":"Anderson","year":"1940","journal-title":"JAMA"},{"key":"10.1016\/j.cccn.2004.09.005_bib54","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1001\/archinte.1939.00180220097009","article-title":"Renal changes following the administration of hypertonic solutions","volume":"63","author":"Lindberg","year":"1939","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.cccn.2004.09.005_bib55","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1001\/archinte.1942.00200160121010","article-title":"Renal lesions following the intravenous injection of hypertonic solution of sucrose: a clinical and experimental study","volume":"69","author":"Rigdon","year":"1942","journal-title":"Arch. Intern. Med."},{"issue":"5","key":"10.1016\/j.cccn.2004.09.005_bib56","doi-asserted-by":"crossref","first-page":"767","DOI":"10.7326\/0003-4819-63-5-767","article-title":"Tubular alterations produced by osmotic diuresis with mannitol","volume":"63","author":"DiScala","year":"1965","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.cccn.2004.09.005_bib57","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1136\/bmj.2.5516.737","article-title":"Acute renal failure associated with low-molecular weight dextran infusion","volume":"2","author":"Morgan","year":"1966","journal-title":"Br. Med. J."},{"key":"10.1016\/j.cccn.2004.09.005_bib58","first-page":"117","article-title":"ASHP therapeutic guidelines for intravenous immune globulin","volume":"11","year":"1992","journal-title":"Clin. Pharm."},{"key":"10.1016\/j.cccn.2004.09.005_bib59","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/0002-9343(87)90110-0","article-title":"Acute cryoglobulinemic renal failure after intravenous infusion of gamma globulin","volume":"82","author":"Barton","year":"1987","journal-title":"Am. J. Med."},{"key":"10.1016\/j.cccn.2004.09.005_bib60","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/0140-6736(91)93395-P","article-title":"High dose intravenous IgG treatment and renal function","volume":"337","author":"Schifferli","year":"1991","journal-title":"Lancet"},{"key":"10.1016\/j.cccn.2004.09.005_bib61","first-page":"83","article-title":"Pulmonary and renal toxicity of intravenous immunoglobulin","volume":"36","author":"Rault","year":"1991","journal-title":"Clin. Nephrol."},{"key":"10.1016\/j.cccn.2004.09.005_bib62","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1056\/NEJM199210013271416","article-title":"High-dose intravenous immune globulin and acute renal failure","volume":"327","author":"Ellie","year":"1992","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.cccn.2004.09.005_bib63","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1111\/j.1423-0410.1993.tb02159.x","article-title":"Renal toxicity of intravenous immunoglobulin","volume":"65","author":"Stewart","year":"1993","journal-title":"Vox Sang."},{"key":"10.1016\/j.cccn.2004.09.005_bib64","first-page":"338","article-title":"Acute renal failure after high-dose intravenous immune globulin in a patient with Idiopathic Thrombocytopenic Purpura","volume":"78","author":"Ruggeri","year":"1993","journal-title":"Haematologica"},{"key":"10.1016\/j.cccn.2004.09.005_bib65","first-page":"347","article-title":"Acute renal failure after intravenous immunoglobulin therapy","volume":"21","author":"Pasatiempo","year":"1994","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.cccn.2004.09.005_bib66","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1001\/archinte.154.17.1985","article-title":"Intravenous immunoglobulin-induced osmotic nephrosis","volume":"154","author":"Ahsan","year":"1994","journal-title":"Arch. Intern. Med."},{"issue":"2","key":"10.1016\/j.cccn.2004.09.005_bib67","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/0272-6386(95)90003-9","article-title":"Acute renal failure associated with immunoglobulin therapy","volume":"25","author":"Cantu","year":"1995","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/j.cccn.2004.09.005_bib68","first-page":"441","article-title":"Hyperoncotic renal failure after intravenous immunoglobulin therapy","volume":"24","author":"Poullin","year":"1995","journal-title":"Presse Med."},{"key":"10.1016\/j.cccn.2004.09.005_bib69","first-page":"862","article-title":"Acute renal failure induced by intravenous immune globulin","volume":"53","author":"Arunabh","year":"1996","journal-title":"Am. Fam. Phys."},{"key":"10.1016\/j.cccn.2004.09.005_bib70","first-page":"295","article-title":"Use of high dose intravenous immunoglobulin in systemic lupus erythematosus: report of three cases","volume":"7","author":"Corvetta","year":"1989","journal-title":"Clin. Exp. Rheumatol."},{"key":"10.1016\/j.cccn.2004.09.005_bib71","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/0140-6736(91)90043-O","article-title":"Intravenous IgG for glomerulonephritis and renal function","volume":"338","author":"Rostoker","year":"1991","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.cccn.2004.09.005_bib72","first-page":"216","article-title":"Renal toxicity of intravenous immunoglobulin","volume":"37","author":"Kobosko","year":"1992","journal-title":"Clin. Nephrol."},{"issue":"4","key":"10.1016\/j.cccn.2004.09.005_bib73","first-page":"217","article-title":"Renal failure and intravenous immunoglobulin","volume":"37","author":"Phillips","year":"1992","journal-title":"Clin. Nephrol."},{"key":"10.1016\/j.cccn.2004.09.005_bib74","first-page":"376","article-title":"Transient renal dysfunction in diabetic patients after IVIG therapy","volume":"232","author":"Donatini","year":"1992","journal-title":"J. Int. Med."},{"key":"10.1016\/j.cccn.2004.09.005_bib75","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1001\/archneur.1993.00540020015010","article-title":"Acute renal failure resulting from intravenous immmunoglobulin therapy","volume":"50","author":"Tan","year":"1993","journal-title":"Arch. Neurol."},{"issue":"6","key":"10.1016\/j.cccn.2004.09.005_bib76","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1002\/j.1875-9114.1995.tb02894.x","article-title":"Acute renal failure after administration of intravenous immunoglobulin: review of the literature and case report","volume":"15","author":"Winward","year":"1995","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.cccn.2004.09.005_bib77","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/S0272-6386(96)90505-3","article-title":"Osmotic nephrosis due to high dose immunoglobulin therapy containing sucrose (but not with glycine) in a patient with immunoglobulin A nephritis","volume":"28","author":"Hansen-Schmidt","year":"1996","journal-title":"Am. J. Kidney Dis."},{"issue":"Suppl. 1","key":"10.1016\/j.cccn.2004.09.005_bib78","first-page":"483","article-title":"Transient renal failure in a patient with Idiopathic Thrombocytopenic Purpura after treatment with concomitant protein-A immunosorption and intravenous immune globulin","volume":"80","author":"Friedman","year":"1992","journal-title":"Blood"},{"key":"10.1016\/j.cccn.2004.09.005_bib79","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1053\/ajkd.2002.35899","article-title":"Acute renal failure in a renal allograft recipient treated with intravenous immunoglobulin","volume":"40","author":"Tsinalis","year":"2002","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/j.cccn.2004.09.005_bib80","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1159\/000179925","article-title":"Pinocytosis as cause of sucrose nephrosis","volume":"8","author":"Schwartz","year":"1971","journal-title":"Nephron"},{"key":"10.1016\/j.cccn.2004.09.005_bib81","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1681\/ASN.V8111788","article-title":"Renal insufficiency following intravenous immune globulin therapy: a report of two cases and analysis of the literature","volume":"8","author":"Cayco","year":"1997","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.cccn.2004.09.005_bib82","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/0140-6736(93)92345-T","article-title":"Hydroxyethylstarch and osmotic-nephrosis-like lesions in kidney transplantation","volume":"342","author":"Legendre","year":"1993","journal-title":"Lancet"},{"key":"10.1016\/j.cccn.2004.09.005_bib83","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1016\/S0140-6736(96)07588-5","article-title":"Effect of hydroxyethylstarch in brain-dead kidney donors on renal function in kidney-transplant recipients","volume":"348","author":"Cittanova","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/j.cccn.2004.09.005_bib84","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1093\/ndt\/14.6.1517","article-title":"Hydroxyethyl starch does not impair immediate renal function in kidney transplant recipients: a retrospective, multicentre analysis","volume":"14","author":"Deman","year":"1999","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.cccn.2004.09.005_bib85","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1016\/S0140-6736(05)66222-8","article-title":"Hydroxyethylstarch and osmotic nephrosis-like lesions in kidney transplants","volume":"348","author":"Bernard","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/j.cccn.2004.09.005_bib86","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/S0002-9343(01)00873-7","article-title":"Acute renal failure secondary to hydroxyethylstarch administration in a surgical patient","volume":"111","author":"LaBarthe","year":"2001","journal-title":"Am. J. Med."},{"key":"10.1016\/j.cccn.2004.09.005_bib87","doi-asserted-by":"crossref","first-page":"2706","DOI":"10.1093\/ndt\/13.10.2706a","article-title":"Hydroxyethylstarch-associated transient acute renal failure after epidural anaesthesia for labour analgesia and caesarean section","volume":"13","author":"Dickenmann","year":"1998","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.cccn.2004.09.005_bib88","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/S0140-6736(00)04211-2","article-title":"Effects of hydroxyethylstarch and gelatin on renal function in severe sepsis: a multicentre randomized study","volume":"357","author":"Schortgen","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.cccn.2004.09.005_bib89","first-page":"375A","article-title":"Hydroxyethylstarch (HES) and the risk of delayed graft function (DGF) following renal transplantation","volume":"13","author":"Edwards","year":"2002","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.cccn.2004.09.005_bib90","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1681\/ASN.V191061","article-title":"Renal aspects of therapy for human immunodeficiency virus and associated opportunistic infections","volume":"1","author":"Berns","year":"1991","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.cccn.2004.09.005_bib91","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1093\/oxfordjournals.ndt.a027276","article-title":"Crystalluria: a neglected aspect of urinary sediment analysis","volume":"11","author":"Fogazzi","year":"1996","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.cccn.2004.09.005_bib92","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1007\/BF02600132","article-title":"Electrolyte and acid\u2013base disorders associated with AIDS: An etiologic review","volume":"9","author":"Perazella","year":"1994","journal-title":"J. Gen. Intern. Med."},{"key":"10.1016\/j.cccn.2004.09.005_bib93","doi-asserted-by":"crossref","first-page":"2379","DOI":"10.1001\/archinte.150.11.2379","article-title":"Sulfadiazine-induced crystalluria revisited. The treatment of Toxoplasma encephalitis in patients with acquired immune deficiency syndrome","volume":"150","author":"Simon","year":"1990","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.cccn.2004.09.005_bib94","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/S0272-6386(88)80076-3","article-title":"Sulfadiazine-associated obstructive nephropathy occurring in a patient with acquired immune deficiency syndrome","volume":"12","author":"Carbone","year":"1988","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/j.cccn.2004.09.005_bib95","first-page":"254","article-title":"Symptomatic sulfadiazine crystalluria in AIDS patients: a report of two cases","volume":"39","author":"Hein","year":"1993","journal-title":"Clin. Nephrol."},{"key":"10.1016\/j.cccn.2004.09.005_bib96","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1148\/radiology.185.3.1438755","article-title":"Renal ultrasound findings in sulfadiazine-induced crystalluria","volume":"185","author":"Sasson","year":"1992","journal-title":"Radiology"},{"key":"10.1016\/j.cccn.2004.09.005_bib97","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1097\/00002030-199105000-00019","article-title":"Sulfadiazine-induced crystalluria in AIDS patients with toxoplasma encephalitis","volume":"5","author":"Molina","year":"1991","journal-title":"AIDS"},{"key":"10.1016\/j.cccn.2004.09.005_bib98","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/pgmj.72.851.557","article-title":"Acute renal failure due to sulfadiazine crystalluria in AIDS patients","volume":"72","author":"de Sequera","year":"1996","journal-title":"Postgrad. Med. J."},{"key":"10.1016\/j.cccn.2004.09.005_bib99","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1177\/106002809603000108","article-title":"Sulfadiazine-induced multiple urolithiasis and acute renal failure in a patient with AIDS and Toxoplasma encephalitis","volume":"30","author":"Diaz","year":"1996","journal-title":"Ann. Pharmacol."},{"key":"10.1016\/j.cccn.2004.09.005_bib100","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1016\/0002-9343(88)90313-0","article-title":"Acyclovir-induced renal failure. Clinical course and histology","volume":"84","author":"Sawyer","year":"1988","journal-title":"Am. J. Med."},{"issue":"Suppl. 1A","key":"10.1016\/j.cccn.2004.09.005_bib101","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/0002-9343(82)90087-0","article-title":"Renal function after acyclovir intravenous injection","volume":"73","author":"Brigden","year":"1982","journal-title":"Am. J. Med."},{"issue":"Suppl. 1A","key":"10.1016\/j.cccn.2004.09.005_bib102","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/0002-9343(82)90086-9","article-title":"Acyclovir tolerance in humans","volume":"73","author":"Keeney","year":"1982","journal-title":"Am. J. Med."},{"key":"10.1016\/j.cccn.2004.09.005_bib103","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1093\/infdis\/151.2.362","article-title":"Adverse effects of high-dose intravenous acyclovir in ambulatory patients with acute herpes zoster","volume":"151","author":"Bean","year":"1985","journal-title":"J. Inf. Disp."},{"key":"10.1016\/j.cccn.2004.09.005_bib104","doi-asserted-by":"crossref","first-page":"312","DOI":"10.7326\/0003-4819-108-2-312_1","article-title":"Low dose acyclovir and acute renal failure (letter)","volume":"108","author":"Giustina","year":"1988","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.cccn.2004.09.005_bib105","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1056\/NEJM199110173251617","article-title":"Acute renal failure and coma after a high dose of oral acyclovir (letter)","volume":"325","author":"Eck","year":"1991","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.cccn.2004.09.005_bib106","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1681\/ASN.V83361","article-title":"Nephrotoxicity of acyclovir and ganciclovir in rats: Evaluation of glomerular hemodynamics","volume":"8","author":"Dos Santos","year":"1997","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.cccn.2004.09.005_bib107","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1097\/00000441-199301000-00007","article-title":"Acyclovir neurotoxicity and nephrotoxicity\u2014the role for hemodialysis","volume":"305","author":"Krieble","year":"1993","journal-title":"Am. J. Med. Sci."},{"key":"10.1016\/j.cccn.2004.09.005_bib108","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1056\/NEJM199709113371102","article-title":"Treatment with indinavir, zidovudine, and lamivudine in adults with Human Immunodeficiency Virus infection and prior antiretroviral therapy","volume":"337","author":"Gulick","year":"1997","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.cccn.2004.09.005_bib109","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1056\/NEJM199701093360215","article-title":"Indinavir nephropathy (letter)","volume":"336","author":"Tashima","year":"1997","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.cccn.2004.09.005_bib110","first-page":"194","article-title":"Indinavir nephropathy in an HIV infected patient with renal insufficiency and pyuria","volume":"50","author":"Perazella","year":"1998","journal-title":"Clin. Nephrol."},{"key":"10.1016\/j.cccn.2004.09.005_bib111","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1016\/S0140-6736(05)62506-8","article-title":"Urinary stones in HIV-1 positive patients treated with indinavir","volume":"349","author":"Daudon","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.cccn.2004.09.005_bib112","doi-asserted-by":"crossref","first-page":"119","DOI":"10.7326\/0003-4819-127-2-199707150-00004","article-title":"Crystalluria and urinary tract abnormalities associated with indinavir","volume":"127","author":"Kopp","year":"1997","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.cccn.2004.09.005_bib113","first-page":"296","article-title":"Indinavir nephrolithiasis in warm climates (letter)","volume":"14","author":"Bach","year":"1997","journal-title":"J. AIDS"},{"key":"10.1016\/j.cccn.2004.09.005_bib114","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/S0272-6386(97)90316-4","article-title":"Acute renal failure due to indinavir crystalluria and nephrolithiasis: report of two cases","volume":"30","author":"Berns","year":"1997","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/j.cccn.2004.09.005_bib115","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1086\/516978","article-title":"Renal dysfunction in a human immunodeficiency virus-infected patient who was treated with indinavir","volume":"25","author":"Grunke","year":"1997","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.cccn.2004.09.005_bib116","doi-asserted-by":"crossref","first-page":"E23","DOI":"10.1053\/ajkd.2001.27732","article-title":"Indinavir nephropathy revisited: a pattern of insidious renal failure with identifiable risk factors","volume":"38","author":"Reilly","year":"2001","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/j.cccn.2004.09.005_bib117","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1007\/BF02054413","article-title":"Prospective, randomized, endoscopic-blinded trial comparing precolonoscopy bowel cleansing methods","volume":"37","author":"Cohen","year":"1984","journal-title":"Dis. Colon Rectum"},{"key":"10.1016\/j.cccn.2004.09.005_bib118","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.humpath.2003.12.005","article-title":"Renal failure due to acute nephrocalcinosis following oral sodium phosphate bowel cleansing","volume":"35","author":"Markowitz","year":"2004","journal-title":"Human Pathol."},{"key":"10.1016\/j.cccn.2004.09.005_bib119","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1159\/000013427","article-title":"Extreme hyperphosphatemia and acute renal failure after a phosphorus-containing bowel regimen","volume":"19","author":"Orias","year":"1999","journal-title":"Am. J. Nephrol."}],"container-title":["Clinica Chimica Acta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898104004334?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898104004334?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,1,15]],"date-time":"2024-01-15T08:23:34Z","timestamp":1705307014000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009898104004334"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,1]]},"references-count":119,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2005,1]]}},"alternative-id":["S0009898104004334"],"URL":"https:\/\/doi.org\/10.1016\/j.cccn.2004.09.005","relation":{},"ISSN":["0009-8981"],"issn-type":[{"value":"0009-8981","type":"print"}],"subject":[],"published":{"date-parts":[[2005,1]]}}}